Quest Diagnostics (DGX)
NYSE: DGX
· Real-Time Price · USD
180.22
1.78 (1.00%)
At close: Aug 15, 2025, 2:55 PM
Quest Diagnostics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 296M | 235M | 222M | 237M | 228M | 208M | 192M | 237M | 249M | 217M | 116M | 276M | 250M | 373M | 413M | 527M | 650M | 490M |
Depreciation & Amortization | 143M | 140M | 135M | 125M | 117M | 116M | 109M | 111M | 112M | 107M | 116M | 108M | 107M | 106M | 106M | 101M | 100M | 101M |
Stock-Based Compensation | 21M | 22M | 27M | 19M | 20M | 22M | 19M | 18M | 16M | 24M | 22M | 18M | 19M | 18M | 19M | 21M | 21M | 18M |
Other Working Capital | 27M | 64M | -56M | -24M | -48M | 80M | -73M | -20M | 12M | 17M | -11M | -13M | -69M | 115M | -48M | -21M | 58M | 2M |
Other Non-Cash Items | 28M | n/a | 67M | 2M | 19M | 12M | 43M | 12M | -2M | 2M | 31M | 4M | 30M | 4M | -5M | -48M | -311M | -2M |
Deferred Income Tax | 1M | 7M | n/a | 15M | -18M | -18M | -10M | -23M | -12M | -4M | -44M | 65M | 23M | -43M | 30M | 2M | -72M | -17M |
Change in Working Capital | 55M | -90M | 13M | -42M | -6M | -186M | 174M | -148M | 81M | -252M | 93M | 31M | -27M | 22M | -82M | -42M | 72M | 139M |
Operating Cash Flow | 544M | 314M | 464M | 356M | 360M | 154M | 527M | 207M | 444M | 94M | 334M | 502M | 402M | 480M | 481M | 561M | 460M | 731M |
Capital Expenditures | -108M | -117M | -123M | -106M | -92M | -104M | -72M | -105M | -104M | -127M | -147M | -118M | -76M | -63M | -144M | -89M | -84M | -86M |
Cash Acquisitions | -17M | n/a | -383M | -1.53B | -106M | -142M | n/a | -2M | -578M | -31M | -38M | n/a | -1M | -105M | -80M | 735M | -231M | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5M | -1M | n/a | n/a | -3M | -7M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5M | 1M | n/a | n/a | 84M | n/a |
Other Investing Acitivies | 1M | 2M | 4M | 6M | -2M | 33M | -42M | n/a | n/a | n/a | 11M | n/a | -5M | -1M | -3M | -742M | 671M | n/a |
Investing Cash Flow | -124M | -115M | -502M | -1.63B | -200M | -213M | -114M | -107M | -682M | -158M | -174M | -118M | -82M | -169M | -227M | -96M | 437M | -93M |
Debt Repayment | n/a | -385M | -1M | 1.84B | -301M | n/a | 471M | -42M | 319M | n/a | -1M | n/a | n/a | -1M | n/a | -1M | n/a | -1M |
Common Stock Repurchased | n/a | n/a | -151M | n/a | n/a | n/a | -275M | -13M | -22M | n/a | -461M | -374M | -200M | -373M | -289M | n/a | -1.5B | -410M |
Dividend Paid | -90M | -84M | -84M | -84M | -84M | -79M | -80M | -80M | -80M | -74M | -75M | -78M | -78M | -74M | -77M | -76M | -81M | -75M |
Other Financial Acitivies | -203M | -92M | 66M | -15M | 6M | -86M | 14M | 39M | -50M | -27M | -8M | -22M | 36M | -23M | -3M | -1M | 14M | -80M |
Financial Cash Flow | -293M | -561M | -170M | 1.77B | -363M | -153M | 130M | -83M | 189M | -76M | -545M | -474M | -242M | -471M | -369M | -38M | -1.57B | -566M |
Net Cash Flow | 131M | -361M | -215M | 493M | -203M | -212M | 543M | 17M | -49M | -140M | -385M | -90M | 78M | -160M | -115M | 427M | -670M | 72M |
Free Cash Flow | 436M | 197M | 341M | 250M | 268M | 50M | 455M | 102M | 340M | -33M | 187M | 384M | 326M | 417M | 337M | 472M | 376M | 645M |